title: How should we introduce clinical positron emission tomography in the UK? Oncologists need to have a (clearer) view.
authors.forename: M
authors.initials: M
authors.lastname: Mac Manus
authors.forename: L
authors.initials: L
authors.lastname: Peters
authors.forename: G
authors.initials: G
authors.lastname: Duchesne
authors.forename: J
authors.initials: J
authors.lastname: Zalcberg
authors.forename: R J S
authors.initials: RJ
authors.lastname: Thomas
authors.forename: D
authors.initials: D
authors.lastname: Ball
authors.forename: R
authors.initials: R
authors.lastname: Hicks
mesh_terms: D004059:Diffusion of Innovation; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000191:economics / Q000706:statistics & numerical data*; D018787:Radiation Oncology / Q000639:trends*; D006113:United Kingdom